HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

RSD 1000

structure in first source

Also Known As:

(+-)-trans-(2-(4-morpholinyl)cyclohexyl)naphthalene-1-acetate mono hydrochloride; RSD-1000; RSD1000

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Oxazines: 9
    - Morpholines: 6
      - RSD 1000: 1

Related Diseases

1.

04/01/1999 - "Mixed ion channel block in ischemic myocardium with minimal effects on normal cardiac tissue, as governed by the low pKa of RSD1000, may account for its antiarrhythmic activity against ischemia-induced arrhythmias."
04/01/1999 - "This study reports the use of a novel agent, RSD1000 [(+/-)-trans-[2-(4-morpholinyl)cyclohexyl]naphthalene-1-acetate mono hydrochloride], to test the hypothesis that a drug with pKa close to the pH found in ischemic tissue may have selective antiarrhythmic actions against ischemia-induced arrhythmias. "

Related Drugs and Biologics

1.	RSD 1000
2.	Ion Channels (Ion Channel)